Metacrine, Inc. Common Stock
MTCR
MTCR was delisted on the 8th of February, 2023.
31 hedge funds and large institutions have $2.23M invested in Metacrine, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 11 closing their positions.
156% more call options, than puts
Call options by funds: $23K | Put options by funds: $9K
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
11% less funds holding
Funds holding: 35 → 31 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
94% less capital invested
Capital invested by funds: $37.9M → $2.23M (-$35.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$352K |
| 2 |
Goldman Sachs
New York
|
+$347K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$298K |
| 4 |
VF
Virtu Financial
New York
|
+$218K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$151K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$10.5M |
| 2 |
VP
venBio Partners
San Francisco,
California
|
-$10.5M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$3.93M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.25M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$965K |
MTCR Hedge Fund Activity: Q4 2021 in Review
31 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q4 2021, worth a combined $2.23M — down 94% from $37.9M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of MTCR and 7 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 10 added.
The largest buyer was Pura Vida Investments, opening a new position worth an estimated $352K. The largest seller was NEA Management Company, exiting entirely with an estimated $10.5M sold.
- 31 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q4 2021, down from 35 in Q3 2021.
- Funds reported $2.23M of Metacrine, Inc. Common Stock stock for Q4 2021, down 94% quarter-over-quarter.
- 7 funds opened new Metacrine, Inc. Common Stock positions in Q4 2021 and 11 closed out, a net change of -4 holders.
- The largest Metacrine, Inc. Common Stock buyer in Q4 2021 was Pura Vida Investments, an estimated $352K added.
- The largest Metacrine, Inc. Common Stock seller in Q4 2021 was NEA Management Company, an estimated $10.5M sold.
Based on aggregated 13F filings for Q4 2021.